Pfizer sues HHS over Medicare rules
(By Katie Adams for Becker’s Hospital Review) Pfizer filed a lawsuit June 26 accusing HHS of blocking it from providing financial aid
Read More
Part D/Prescription Drugs
Gilead announces long-awaited price for Covid-19 drug remdesivir
(By Matthew Herper for STAT) Since remdesivir became the first medicine shown to have an impact on Covid-19, doctors, politicians,
Read MoreCoalition of drugmakers to unveil $1B venture to pursue antibiotics
(By Katie Adams for Becker’s Hospital Review) Several of the pharmaceutical industry’s top drugmakers are forming a $1 billion antibiotic innovation
Read MoreRegeneron paid patient charity millions in kickbacks, lawsuit claims
(By Maia Anderson for Becker’s Hospital Review) The U.S. government filed a lawsuit against Regeneron Pharmaceuticals June 24 alleging the
Read MoreFDA urged to increase safety warnings on common diabetes drug
(By Maia Anderson for Becker’s Hospital Review) Public Citizen, a consumer advocacy group, filed a citizen’s petition June 24 urging the
Read MoreMost people think COVID-19 will raise drug prices and health insurance premiums
According to a new survey, 90 percent of Americans are “very” or “somewhat” worried that COVID-19 will cause high drug
Read MoreGeneric remdesivir to cost up to $79 per dose
(By Alia Paavola for Becker’s Hospital Review) Two generic drugmakers, Cipla and Hetero, were given the green light from Indian regulators
Read MoreMedicare Savings Programs
If you have Medicare and need help with your health care costs, there are programs to help. Depending on your
Read MoreNearly 90% of Americans worried about drug price hikes
(ByKatie Adams for Becker’s Hospital Review) Nearly 90 percent of Americans expressed concern about drugmakers using the pandemic as an
Read MoreNew CMS rule promotes payer drug price negotiations based on clinical outcomes
(By Maia Anderson for Becker’s Hospital Review) CMS issued a proposed rule June 17 that would make it easier for Medicaid
Read More